206 related articles for article (PubMed ID: 29077150)
1. Analysis of changes in joint function and peripheral blood mononuclear cells in patients with systemic lupus erythematosus and intervention effects of different drugs.
Zhou QS; Hu J; Hu H
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4423-4430. PubMed ID: 29077150
[TBL] [Abstract][Full Text] [Related]
2. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
[TBL] [Abstract][Full Text] [Related]
3. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.
Tam LS; Li EK; Wong CK; Lam CW; Szeto CC
Lupus; 2004; 13(8):601-4. PubMed ID: 15462490
[TBL] [Abstract][Full Text] [Related]
5. TRAIL mRNA expression in peripheral blood mononuclear cells of Egyptian SLE patients.
El-Karaksy SM; Kholoussi NM; Shahin RM; El-Ghar MM; Gheith Rel-S
Gene; 2013 Sep; 527(1):211-4. PubMed ID: 23792015
[TBL] [Abstract][Full Text] [Related]
6. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
[TBL] [Abstract][Full Text] [Related]
7. Micronucleus frequency in peripheral blood lymphocytes from patients with systemic lupus erythematosus.
Severin E
Rom J Morphol Embryol; 1995; 41(1-2):55-8. PubMed ID: 8680026
[TBL] [Abstract][Full Text] [Related]
8. Complete urological evaluation including sperm DNA fragmentation in male systemic lupus erythematosus patients.
Tiseo BC; Bonfá E; Borba EF; Munhoz GA; Wood G; Srougi M; Silva CA; Cocuzza M
Lupus; 2019 Jan; 28(1):59-65. PubMed ID: 30509155
[TBL] [Abstract][Full Text] [Related]
9. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.
Karonitsch T; Feierl E; Steiner CW; Dalwigk K; Korb A; Binder N; Rapp A; Steiner G; Scheinecker C; Smolen J; Aringer M
Arthritis Rheum; 2009 May; 60(5):1463-71. PubMed ID: 19404947
[TBL] [Abstract][Full Text] [Related]
10. Leflunomide: friend or foe for systemic lupus erythematosus?
Wu GC; Xu XD; Huang Q; Wu H
Rheumatol Int; 2013 Feb; 33(2):273-6. PubMed ID: 22961090
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
[TBL] [Abstract][Full Text] [Related]
12. Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio.
Cipriano E; Ceccarelli F; Massaro L; Spinelli FR; Alessandri C; Perricone C; Valesini G; Conti F
Reumatismo; 2015 Sep; 67(2):62-7. PubMed ID: 26492964
[TBL] [Abstract][Full Text] [Related]
13. Elevated Layilin-Positive Monocyte Levels in the Peripheral Blood of Patients with Systemic Lupus Erythematosus Reflect Their Autoimmune Status.
Liu C; Wang Y; Zhang YH; Yuan Z; Zhang Z; Zeng X; Guan Z; Bahabayi A; Lu S
Immunol Invest; 2023 Nov; 52(7):879-896. PubMed ID: 37642473
[TBL] [Abstract][Full Text] [Related]
14. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
16. [A study of T cell recombination excision circles levels in peripheral blood mononuclear cells of systemic lupus erythematosus patients].
Du ZY; Leng XM; Tang FL
Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):500-3. PubMed ID: 20979738
[TBL] [Abstract][Full Text] [Related]
17. Octreotide for the treatment of systemic lupus erythematosus: clinical effects and an in vitro study on its therapeutic mechanism.
Zhang Y; Huang W; Li F; Feng S; Kang K; Xu J
Lupus; 2011 Oct; 20(11):1172-81. PubMed ID: 21979989
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus.
Tsujimura S; Saito K; Nakayamada S; Nakano K; Tanaka Y
Arthritis Rheum; 2005 Jun; 52(6):1676-83. PubMed ID: 15934077
[TBL] [Abstract][Full Text] [Related]
19. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus.
Perniok A; Wedekind F; Herrmann M; Specker C; Schneider M
Lupus; 1998; 7(2):113-8. PubMed ID: 9541096
[TBL] [Abstract][Full Text] [Related]
20. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
Wei S; Yoshida N; Finn G; Kozono S; Nechama M; Kyttaris VC; Zhen Zhou X; Tsokos GC; Ping Lu K
Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
